The Smallest Pacemakerons On Display At The Inaugural Fair Have Been Approved For Domestic Listing

The benefits to businesses and Chinese consumers of the first China International Import Expo are real. Reporters learned that the first star products at the Expo - Medtroncorporation in the United States brought the world's smallest pacemaker Micra has been approved in June this year in the domestic listing.

Micra, the world's smallest pacemaker.

The traditional pacemaker is about the size of a tea bag and needs to be implanted into the chest, while Micra is a wireless pacemaker, 25.9 mm long, 1.0 cubic centimeters in volume, weighing only 2 grams, 90% smaller than a conventional heart starter, and the size of only one coin.

Micra's wireless pacemaker is a product of Medtronic, a U.S. medical technology company that was approved for sale in Europe and the United States in 2015 and 2016. In 2018, Micra has started pre-market clinical research in seven domestic hospitals, including the Chinese Academy of Medical Sciences, in accordance with the regulations of the State Administration of Market Supervision and Administration, with a total of more than 80 patients enrolled.

A month after the Expo, according to the relevant policy provisions, Hainan Boao Super Hospital implanted Micra wireless pacemaker for patients with multiple infections after the implantation of a traditional pacemaker, which is the first market-oriented application of Micra wireless pacemaker in China.

On June 11, 2019, the State Drug Administration officially announced the approval of Micra's domestic market through the Special Approval Process for Innovative Medical Devices.

Medtronic company related to reporters, this year, Medtronic will bring nearly 50 advanced medical technology products, focusing on intelligent, early diagnosis and treatment, minimally invasive treatment and telemedicine and other international medical trends, covering intelligent surgery, neurospinal surgery, heart and vascular surgery, surgical monitoring and recovery, early diagnosis and slow disease management and other fields. These include the world's first neonatal hemodialysis system, The Mazor X of Medtronic's professional intelligent spinal robot system, which was unveiled in China, and a retrospective continuous glucose monitoring system that rewrites the treatment of hypertension, a renal arterial radiofrequency ablation catheter used to treat refractive hypertension, and a retrospective continuous glucose monitoring system that continuously monitors blood sugar levels and optimizes diabetes management.